Inhibition of isolated yeast and mycelial phase RNA polymerases of Histoplasma capsulatum by rifamycin derivatives.
Various derivatives of rifamycin were shown to inhibit the RNA polymerases of the yeast and mycelial phases of Histoplasma capsulatum. The relative potency of each of the derivatives against the isolated polymerases was the same as the potency of each against the viable organism. RNA polymerase PC III from the yeast phase was more susceptible to the rifamycin derivatives than yeast phase polymerases PC I and PC II and the biggest differences in susceptibility were seen with the derivative AF/ABDP (2,6-dimethyl-4-benzyl-4-demethyl-rifamycin). The susceptibility pattern of the mycelial polymerase activity was identical to the yeast polymerase PC III.
D002454:Cell Differentiation; D012321:DNA-Directed RNA Polymerases / Q000037:antagonists & inhibitors*; D006658:Histoplasma / Q000166:cytology / Q000201:enzymology*; D012294:Rifamycins / Q000494:pharmacology*; D013329:Structure-Activity Relationship
D012294:Rifamycins; D012321:DNA-Directed RNA Polymerases